Try digitalPLUS for 10 days for only $0.99

Business

Business

MedImmune, UM Baltimore to make drugs together

Drug maker MedImmune and the University of Maryland, Baltimore have entered into a $6 million partnership to conduct bioscience research.

Under the five-year agreement, Gaithersburg-based MedImmune and the university will provide funding and scientists to work on joint research they hope will result in quicker development of drugs.

The research will focus on cardiovascular and metabolic disease; oncology; respiratory, inflammation and autoimmunity; and infectious disease – areas MedImmune is already strong in.

MedImmune will contribute $5 million and the university $1 million.

The University of Maryland, College Park and University of Maryland, Baltimore County are also a part of the collaboration.

The Department of Business & Economic Development will also contribute funding based on what is available during the five years.

andrea.walker@baltsun.com

Twitter.com/ankwalker

Copyright © 2015, The Baltimore Sun
Related Content
  • Baltimore People on the Move archive

    Baltimore People on the Move archive

    Readers submit photos and information on employees who have recently been promoted, hired or honored at area businesses. Select photos will be published in the Maryland Business section of Tuesday editions of The Baltimore Sun. Caption size is limited and only photos are accepted in this feature....

  • Health Professionals on the Move: June 2015

    Health Professionals on the Move: June 2015

    Readers submit photos and information on medical professionals who have recently been promoted, hired or honored. Select photos will be published in the Health and Medicine section of Sunday's edition of The Baltimore Sun. Only photos are accepted. (Caption size is limited.)

Comments
Loading

66°